Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
therapeutics tags : Earnings save search
AN2 Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business and Scientific Highlights
Published: 2024-03-28 (Crawled : 22:00) - biospace.com/
ANTX | $2.43 2.1% 2.06% 100K
|
|
| O: 0.31%
H: 4.64%
C: 0.62%
business year therapeutics financial results
Virpax Pharmaceuticals Reports 2023 Year-End Results
Published: 2024-03-26 (Crawled : 20:00) - biospace.com/
VRPX | $3.86 -4.46% -4.66% 6K
|
|
| O: -0.68%
H: 3.17%
C: 2.65%
SRNE | $0.024 -8.85% 57K
|
Health Technology
|
| O: 11.11%
H: 0.0%
C: -10.0%
virpax pharmaceuticals results
Correction - Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 28, 2024Live Conference Call and Webcast at 8:30 a.m. ET
Published: 2024-03-21 (Crawled : 12:00) - biospace.com/
AGRX | $0.37 0.0% 15K
|
Health Technology
|
| O: 0.17%
H: 0.0%
C: -3.28%
conference report business year update therapeutics financial results
Relmada Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results
Published: 2024-03-19 (Crawled : 22:00) - biospace.com/
RLMD | $4.0 -6.98% -7.5% 150K
|
Health Technology
|
| O: 0.0%
H: 5.8%
C: -2.72%
update therapeutics financial results
Cyclo Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
Published: 2024-03-18 (Crawled : 15:30) - biospace.com/
CYTH | $1.19 -0.83% -0.84% 57K
|
Professional, Scientific, and T...
|
| O: -6.06%
H: 10.32%
C: 3.23%
RFL 4 | $1.76 2.92% 0.0% 26K
|
Finance
|
| O: -1.16%
H: 3.51%
C: -0.58%
business year update therapeutics financial results
Tango Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Highlights
Published: 2024-03-18 (Crawled : 12:00) - biospace.com/
TNGX | $7.33 -0.54% -0.55% 530K
|
|
| O: -3.54%
H: 2.18%
C: -3.67%
business year therapeutics financial results
Silence Therapeutics Reports Full Year 2023 Financial Results and Recent Business Highlights
Published: 2024-03-13 (Crawled : 15:00) - biospace.com/
SLN | $22.75 3.32% 3.21% 310K
|
Health Technology
|
| O: -5.02%
H: 5.71%
C: 4.11%
business year therapeutics financial results
Sangamo Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-03-13 (Crawled : 13:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
SGMO | $0.5143 6.02% 5.68% 1M
|
Health Technology
|
| O: 2.19%
H: 4.55%
C: -10.78%
business year therapeutics financial results
Design Therapeutics to Webcast Fourth Quarter and Full Year 2023 Financial Results and Comprehensive Portfolio Update
Published: 2024-03-12 (Crawled : 11:00) - biospace.com/
DSGN | $3.695 -1.2% -1.22% 390K
|
Professional, Scientific, and T...
|
| O: 0.0%
H: 1.09%
C: -1.82%
year update design therapeutics financial results
Cadrenal Therapeutics Provides Fourth Quarter 2023 Corporate Update
Published: 2024-03-11 (Crawled : 17:00) - biospace.com/
CVKD | $0.401 -6.7% -7.18% 67K
|
|
| O: -4.12%
H: 5.84%
C: 1.37%
update therapeutics
Astria Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update
Published: 2024-03-04 (Crawled : 22:00) - biospace.com/
ATXS | $9.745 -7.54% -8.16% 1.2M
|
Manufacturing
|
| O: 0.67%
H: 0.46%
C: -5.44%
year update therapeutics financial results
Sarepta Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Recent Corporate Developments
Published: 2024-02-28 (Crawled : 00:00) - biospace.com/
SRPT | $115.53 -0.88% -0.9% 640K
|
Health Technology
|
| O: -0.28%
H: 1.03%
C: -2.58%
therapeutics financial results
Silence Therapeutics to Report Fourth Quarter and Full Year 2023 Results on March 13, 2024
Published: 2024-02-28 (Crawled : 13:30) - biospace.com/
SLN | $22.75 3.32% 3.21% 310K
|
Health Technology
|
| O: -0.47%
H: 5.04%
C: 1.06%
report year therapeutics results
Protagonist Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Published: 2024-02-27 (Crawled : 00:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -1.07%
H: 0.0%
C: 0.0%
PTGX | $25.61 1.55% 1.52% 450K
|
Health Technology
|
| O: 0.3%
H: 1.25%
C: -0.1%
year update financial results
Viridian Therapeutics Highlights Recent Progress and Reports Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-02-27 (Crawled : 00:00) - biospace.com/
VRDN | $14.59 -3.76% -3.91% 1.5M
|
Health Care and Social Assistan...
|
| O: 1.09%
H: 2.57%
C: 0.67%
year therapeutics financial results
Karyopharm to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024
Published: 2024-02-22 (Crawled : 15:30) - biospace.com/
KPTI | $1.16 -9.38% -10.34% 1.4M
|
Health Technology
|
| O: 0.83%
H: 2.05%
C: -7.38%
report year financial results
Edgewise Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
Published: 2024-02-22 (Crawled : 15:30) - biospace.com/
EWTX | $15.23 -1.42% -1.44% 540K
|
Manufacturing
|
| O: 0.06%
H: 5.31%
C: -0.8%
business year therapeutics financial results
Revance to Release Fourth Quarter and Full Year 2023 Financial Results on Wednesday February 28, 2024
Published: 2024-02-21 (Crawled : 15:30) - biospace.com/
VTRS | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: -0.15%
H: 0.76%
C: 0.3%
RVNC | $3.77 -0.53% -0.53% 1.6M
|
Health Technology
|
| O: 0.18%
H: 0.72%
C: -2.72%
year financial results
Sarepta Therapeutics to Announce Fourth Quarter and Full-Year 2023 Financial Results
Published: 2024-02-21 (Crawled : 15:30) - biospace.com/
SRPT | $115.53 -0.88% -0.9% 640K
|
Health Technology
|
| O: -0.97%
H: 1.06%
C: -1.88%
therapeutics financial results
United Therapeutics Corporation Reports Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-02-21 (Crawled : 12:00) - biospace.com/
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -2.33%
H: 1.55%
C: 1.06%
UTHR | $237.99 0.45% 0.45% 400K
|
Health Technology
|
| O: 2.59%
H: 3.66%
C: -0.24%
year corporation therapeutics financial results
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | News | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.